Synthesis of novel imidazo[4,5-b]indoles shows significant inhibition of peroxidase, AChE, and BChE, suggesting potential in Alzheimer's treatment.
We herein report the design, synthesis, and biological activities of substituted imidazo[4,5-b] indoles 5(a–f) as a powerful antioxidant and anti-Alzheimer's disease activity. The synthesized molecules were characterized using spectroscopic techniques, including infrared spectroscopy, nuclear magnetic resonance (1H and13C), mass spectrometry, and elemental analysis. The predictions regarding drug-likeness and toxicity, including favorable bioavailability of all the synthesized compounds, were disclosed. Furthermore, these newly synthesized compounds 5(a–f) demonstrated excellent inhibitory potential against peroxidase, acetylcholinesterase (AChE), and butyrylcholinesterase (BChE). Among the compounds, compound 5f showed excellent inhibitory activity with IC50 values of 08.52 ± 0.32 μM, 05.29 ± 0.09 μM, and 08.28 ± 0.10 μM against peroxidase, AChE, and BChE, respectively. Finally, the compounds described above were subjected to in silico molecular modeling against cytochrome c peroxidase (PDB ID: 2X08), AChE (PDB ID: 7E3H), and BChE (PDB ID: 4BDS). The compounds exhibited excellent binding interactions with all the proteins synthesized above.
No takes yet. Share an insight, caveat, or question.
T et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: